Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arjun Datt Law

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Hematology/Oncology and Stem Cell Therapy|March 29, 2021
Predictors of Outcomes of Therapy-Related Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell TransplantationRam Vasudevan Nampoothiri, Arjun Datt Law, Wilson Lam, et al.
European Journal of Haematology|May 29, 2025
Impact of Conditioning Intensity on Survival in Adult Patients (< 65 Years) With Acute Myeloid Leukemia Receiving Antithymocyte Globulin and Post-Transplantation Cyclophosphamide Based GVHD ProphylaxisAhmed Alnughmush, Ruah Alyamany, Mats Remberger, et al.
Blood Advances|March 23, 2021
Azacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AMLFiras El Chaer, Uma Borate, Rémy Duléry, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 16, 2022
Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantationShruti Prem, Mats Remberger, Ahmad Alotaibi, et al.
Transplantation and Cellular Therapy|March 10, 2024
Pretransplant Blinatumomab Improves Outcomes in B Cell Acute Lymphoblastic Leukemia Patients Who Undergo Allogeneic Hematopoietic Cell TransplantationAyman Sayyed, Carol Chen, Armin Gerbitz, et al.
British Journal of Haematology|August 27, 2025
A decade of experience using ATG and PTCy for graft-versus-host disease prophylaxis in matched unrelated donor allogeneic haematopoietic cell transplantationNihar Desai, Sergio Rodriguez-Rodriguez, Eshrak Al-Shaibani, et al.
European Journal of Haematology|May 8, 2025
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic/Myeloproliferative Overlap NeoplasmsNihar Desai, Sergio Rodriguez-Rodriguez, Carol Chen, et al.
European Journal of Haematology|October 13, 2020
Prolactin, a potential biomarker for chronic GVHD activityMaria Queralt Salas, Shereen Ezzat, Wilson Lam, et al.
Transplantation and Cellular Therapy|May 9, 2021
Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell TransplantationMaria Queralt Salas, Eshetu G Atenafu, Arjun Datt Law, et al.
Hematology/Oncology and Stem Cell Therapy|October 13, 2020
Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantationRam Vasudevan Nampoothiri, Shiyi Chen, Ivan Pasic, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Hematology/Oncology and Stem Cell Therapy|March 29, 2021
Predictors of Outcomes of Therapy-Related Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell TransplantationRam Vasudevan Nampoothiri, Arjun Datt Law, Wilson Lam, et al.
European Journal of Haematology|May 29, 2025
Impact of Conditioning Intensity on Survival in Adult Patients (< 65 Years) With Acute Myeloid Leukemia Receiving Antithymocyte Globulin and Post-Transplantation Cyclophosphamide Based GVHD ProphylaxisAhmed Alnughmush, Ruah Alyamany, Mats Remberger, et al.
Blood Advances|March 23, 2021
Azacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AMLFiras El Chaer, Uma Borate, Rémy Duléry, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 16, 2022
Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantationShruti Prem, Mats Remberger, Ahmad Alotaibi, et al.
Transplantation and Cellular Therapy|March 10, 2024
Pretransplant Blinatumomab Improves Outcomes in B Cell Acute Lymphoblastic Leukemia Patients Who Undergo Allogeneic Hematopoietic Cell TransplantationAyman Sayyed, Carol Chen, Armin Gerbitz, et al.
British Journal of Haematology|August 27, 2025
A decade of experience using ATG and PTCy for graft-versus-host disease prophylaxis in matched unrelated donor allogeneic haematopoietic cell transplantationNihar Desai, Sergio Rodriguez-Rodriguez, Eshrak Al-Shaibani, et al.
European Journal of Haematology|May 8, 2025
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic/Myeloproliferative Overlap NeoplasmsNihar Desai, Sergio Rodriguez-Rodriguez, Carol Chen, et al.
European Journal of Haematology|October 13, 2020
Prolactin, a potential biomarker for chronic GVHD activityMaria Queralt Salas, Shereen Ezzat, Wilson Lam, et al.
Transplantation and Cellular Therapy|May 9, 2021
Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell TransplantationMaria Queralt Salas, Eshetu G Atenafu, Arjun Datt Law, et al.
Hematology/Oncology and Stem Cell Therapy|October 13, 2020
Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantationRam Vasudevan Nampoothiri, Shiyi Chen, Ivan Pasic, et al.
Pageof 7